<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03399162</url>
  </required_header>
  <id_info>
    <org_study_id>20170698</org_study_id>
    <nct_id>NCT03399162</nct_id>
  </id_info>
  <brief_title>PRehabilitiation in Elective Frail and Elderly Cardiac Surgery PaTients</brief_title>
  <acronym>PREFECT</acronym>
  <official_title>PRehabilitiation in Elective Frail and Elderly Cardiac Surgery PaTients (PREFECT): Assessing the Impact of a Personalized Prehabilitation Program Before Cardiac Surgery on Frailty and Clinical Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ottawa Heart Institute Research Corporation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ottawa Heart Institute Research Corporation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Older and more frail adults are more often being referred for cardiac surgery. These patients
      are often in suboptimal health, and may be physically frail, malnourished, and have other
      conditions, such as diabetes, that complicate their recovery. Research suggests that a
      rehabilitation program prior to surgery may help improve participants' health and improve
      their fitness for surgery. Currently, a pre-operative rehabilitation workshop is offered at
      the University of Ottawa Heart Institute, but this interventional, randomized study will
      investigate whether a more comprehensive pre-operative regime, including structured weekly
      exercise program, is more effective at improving health prior to surgery. Patients will be
      randomized to either the control group (pre-operative rehabilitation workshop ONLY) or the
      treatment group (pre-operative rehabilitation workshop plus exercise regime). This regime
      will attempt to improve patients' overall health, including their physical fitness and
      nutritional status. The effectiveness of this regime will be evaluated by comparing patients'
      physical function, questionnaires (diet, quality of life, stress) and serum biomarkers from
      baseline to pre-surgery to post-surgery. The Investigators hypothesize that patients that
      complete the pre-operative rehabilitation program will improve their health prior to surgery,
      and that this may result in shorter length of hospitalization and fewer complications after
      surgery. The study will take place over two years, with each patient's participation lasting
      about 3 months.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Frailty is a common syndrome among older adults, defined as a &quot;clinically recognizable state
      of increased vulnerability resulting from aging-associated decline in reserve and function&quot;.
      Fried defined frailty as meeting three out of the five criteria: low grip strength, low
      energy, slowed walking speed, low physical activity, and/or unintentional weight loss.
      Clinicians are currently challenged with a rising prevalence of elderly and frail patients
      presenting for major cardiac surgery. Such patients typically present with a greater
      comorbidity burden and are more likely to be malnourished, physically deconditioned, and to
      exhibit decreased physiological adaptation to stress. Frail cardiac surgical patients are,
      unsurprisingly, at increased risk for major adverse cardiac and cerebrovascular events,
      short- and longer-term mortality, and increased length of hospital of stay. Clinicians may
      also struggle to quantify the peri-operative risk of morbidity and mortality among these
      individuals, since tools such as the Society of Thoracic Surgeons (STS) risk assessment are
      not designed to comprehensively assess the complex interaction between various risk factors
      seen in the frail patient.

      Cardiovascular rehabilitation (CR) programs are integral to managing patients with
      cardiovascular disease. Such programs include health behaviour change, and cardiovascular
      risk factor management (e.g. moderate-to-vigorous-intensity continuous exercise training
      [MICE], healthy eating, smoking cessation, stress management, and psychological services).
      The benefits of MICE for patients with cardiovascular disease include improvements in
      exercise tolerance, muscular strength, cardiovascular health and reduced hospitalizations.
      MICE is, therefore, able to improve several facets of physical dysfunction, and forms major
      therapeutic interventions for functional capacity and frailty. Improvements in nutritional
      status have been observed in patients with cardiovascular disease(CVD) participating in CR,
      and exercise training and stress management have been shown to reduce distress in CVD
      patients.

      Emerging evidence indicates that CR before cardiac surgery (i.e. prehabilitation [PREHAB])
      may improve clinical outcomes. Sawatzky et al. showed that a 12-week PREHAB program
      consisting of two structured exercise training sessions per week and 12 education sessions
      concerning cardiovascular risk factor management, exercise, stress, diet, and medication use
      in patients awaiting coronary artery bypass grafting (CABG) was feasible and significantly
      improved functional capacity.

      Elderly and frail patients are increasingly presenting for cardiac surgery, and these
      individuals must be carefully optimized pre-operatively to increase the likelihood of their
      recovery and return to a reasonable quality of life. A personalized PREHAB program that
      targets and ameliorates the elements of frailty, including low functional capacity, poor
      nutrition, and stress, offers the best chance of mitigating frailty and its associated risk
      factors in a way that is feasible, patient-centred, and translatable to other cardiovascular
      centres. This project will use objective measures, including tests of functional capacity,
      validated questionnaires, and biomarker analysis, to better quantify the subjective diagnosis
      of frailty in our patients, and will implement a novel personalized PREHAB program with
      integrated on-site and home-based exercise sessions, in an attempt to mitigate the frailty
      and other risk factors that impact patients in the peri-operative period.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 2018</start_date>
  <completion_date type="Anticipated">August 2019</completion_date>
  <primary_completion_date type="Anticipated">February 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Functional capacity</measure>
    <time_frame>Change between baseline and 8 weeks (+/- 1 week)</time_frame>
    <description>The primary outcome, functional capacity, will be measured using the 6-minute walk test.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Frailty (Fried criteria)</measure>
    <time_frame>Compared between baseline, 8 weeks (+/- 1 week), and 4 weeks after surgery (+/- 2 weeks)</time_frame>
    <description>Measured using the Fried frailty score (presence of 3 of the 5 symptoms of frailty)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frailty (clinical score)</measure>
    <time_frame>Compared between baseline, 8 weeks (+/- 1 week), and 4 weeks after surgery (+/- 2 weeks)</time_frame>
    <description>Measured using the Clinical Frailty Scale (9 point clinical assessment)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>Compared between baseline, 8 weeks (+/- 1 week), and 4 weeks after surgery (+/- 2 weeks)</time_frame>
    <description>Measured using the SF-36 Quality of Life questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression</measure>
    <time_frame>Compared between baseline, 8 weeks (+/- 1 week), and 4 weeks after surgery (+/- 2 weeks)</time_frame>
    <description>Measured using the BDI-II</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety</measure>
    <time_frame>Compared between baseline, 8 weeks (+/- 1 week), and 4 weeks after surgery (+/- 2 weeks)</time_frame>
    <description>Measured using the BAI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dietary habits</measure>
    <time_frame>Compared between baseline, 8 weeks (+/- 1 week), and 4 weeks after surgery (+/- 2 weeks)</time_frame>
    <description>Measured using the Block food frequency questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exercise adherence</measure>
    <time_frame>Compared between baseline and 8 weeks (+/- 1 week)</time_frame>
    <description>Measured using a pedometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical and cardiovascular outcomes</measure>
    <time_frame>In the 6 weeks after surgery</time_frame>
    <description>A composite endpoint that will look at the rates of occurrence of major cardiovascular and cerebrovascular outcomes (i.e. death, myocardial infarction, cardiac arrest, stroke) and length of hospitalization.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Biomarkers</measure>
    <time_frame>Compared between baseline and 8 weeks (+/- 1 week)</time_frame>
    <description>An exploratory outcome where we will examine a panel of biomarkers to determine the biomarker profile of frail and elderly patients referred for cardiac surgery, and to observe what changes, if any, occur after the PREHAB intervention. The biomarker panel includes markers of cardiovascular health and risk (NT-pro BNP, cholesterol, homocysteine), nutritional status (albumin, prealbumin, trasnferrin receptor, 25-hydroxy-vitamin D), inflammation (interleukin 6, selenium, high sensitivity CRP, sRAGE), renal function (creatinine, cystatin C), liver function (AST, ALT), and overall health (CBC, adiponectin, dehydroepiandrosterone sulfate, sex hormone-binding globulin, insulin-like growth factor).</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">132</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Valvular Heart Disease</condition>
  <arm_group>
    <arm_group_label>PREHAB Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this arm will receive the usual standard of care prior to surgery, which includes a PREHAB workshop; consultations with a surgeon, anaesthesiologist, and nurse; referrals to diabetes counselling and/or smoking cessation, as appropriate; and the usual diagnostic work-up.
Patients in this group will also complete an 8-week PREHAB exercise program, with weekly exercise classes and a list of exercises to complete at home.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of care group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this arm will receive the usual standard of care prior to surgery, which includes a PREHAB workshop; consultations with a surgeon, anaesthesiologist, and nurse; referrals to diabetes counselling and/or smoking cessation, as appropriate; and the usual diagnostic work-up.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>PREHAB Workshop</intervention_name>
    <description>PREHAB workshop/education session in the Prevention and Rehabilitation Centre regarding nursing, nutrition, physiotherapy, psychology, and diabetes.</description>
    <arm_group_label>PREHAB Group</arm_group_label>
    <arm_group_label>Standard of care group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>PREHAB Exercise Program</intervention_name>
    <description>An 8-week program that consists of: (1) 2x/week 60-minute supervised exercise sessions; and (2) 3x/week 30-minute home-based exercise sessions.</description>
    <arm_group_label>PREHAB Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients &gt;18 years of age

          -  Patients able to provide informed consent

          -  Patients undergoing elective cardiac surgery for either CABG, valve, or CABG + valve

          -  Patients who have an estimated wait time of at least 10 weeks.

          -  Patients who are either â‰¥65 years of age or classified as frail using Fried Frailty
             criteria or scoring at least 3 on the Clinical Frailty Scale

        Exclusion Criteria:

          -  Patients with current or recent unstable cardiac disease, defined as and of the
             following:

          -  CCS class IV angina,

          -  NYHA Class III or IV heart failure,

          -  Critical left main disease,

          -  hospitalization for arrhythmia within the last month

          -  Dynamic ventricular outflow obstruction

          -  Symptomatic exercise-induced arrhythmia

          -  Patients who are cognitively, geographically or physically unable to complete the
             PREHAB sessions

          -  Patients who, in the opinion of either their treating physician or the study
             investigators, should not participate in a pre-operative rehabilitation program.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juan B Grau Alvaro, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ottawa Heart Institute Research Corporation</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Louise Sun, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ottawa Heart Institute Research Corporation</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jennifer Reed, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ottawa Heart Institute Research Corporation</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jacqueline H Fortier, MSc</last_name>
    <phone>613-696-7000</phone>
    <phone_ext>18329</phone_ext>
    <email>jfortier@ottawaheart.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Ottawa Heart Institute</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1Y4W7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Juan Grau Alvaro, MD</last_name>
      <phone>613-696-7291</phone>
      <email>jgrau@ottawaheart.ca</email>
    </contact>
    <contact_backup>
      <last_name>Jacqueline Fortier, MSc</last_name>
      <phone>613-696-7000</phone>
      <phone_ext>18329</phone_ext>
      <email>jfortier@ottawaheart.ca</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA; Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56.</citation>
    <PMID>11253156</PMID>
  </reference>
  <reference>
    <citation>Afilalo J, Mottillo S, Eisenberg MJ, Alexander KP, Noiseux N, Perrault LP, Morin JF, Langlois Y, Ohayon SM, Monette J, Boivin JF, Shahian DM, Bergman H. Addition of frailty and disability to cardiac surgery risk scores identifies elderly patients at high risk of mortality or major morbidity. Circ Cardiovasc Qual Outcomes. 2012 Mar 1;5(2):222-8. doi: 10.1161/CIRCOUTCOMES.111.963157. Epub 2012 Mar 6.</citation>
    <PMID>22396586</PMID>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 20, 2017</study_first_submitted>
  <study_first_submitted_qc>January 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 16, 2018</study_first_posted>
  <last_update_submitted>April 10, 2018</last_update_submitted>
  <last_update_submitted_qc>April 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Valve Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

